A detailed history of Wealthedge Investment Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wealthedge Investment Advisors, LLC holds 2,833 shares of CRL stock, worth $387,356. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,833
Holding current value
$387,356
% of portfolio
0.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$150.52 - $190.14 $426,423 - $538,666
2,833 New
2,833 $426 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $6.95B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wealthedge Investment Advisors, LLC Portfolio

Follow Wealthedge Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthedge Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthedge Investment Advisors, LLC with notifications on news.